Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes

Background. Patients with prediabetes are at high risk for diabetes and cardiovascular disease (CVD). No study has explored whether intervention could revert prediabetes to normal glycemic status as the primary outcome. Beijing Prediabetes Reversion Program (BPRP) would evaluate whether intensive li...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Diabetes Res
Asıl Yazarlar: Luo, Yingying, Paul, Sanjoy K., Zhou, Xianghai, Chang, Cuiqing, Chen, Wei, Guo, Xiaohui, Yang, Jinkui, Ji, Linong, Wang, Hongyuan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi Publishing Corporation 2017
Konular:
Clinical Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266841/
https://ncbi.nlm.nih.gov/pubmed/28168204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7602408
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller